The move
Recent news highlights a 12% gain in the past month, driven by strong adoption of its da Vinci 5 system and expanding international markets.
Market intelligence · independent judgment
US stocks, screened after the close. Quantitative signals and AI analysis, so you can see what deserves a closer look.
NASDAQ
Intuitive Surgical (ISRG) is poised for a potential breakout ahead of its Q3 earnings release on October 20. The company has demonstrated strong fundamentals, including double-digit earnings and revenue growth, and a debt-free balance sheet.
At the time of the selection
Fuse Score = 60% Quant Score + 40% AI Score
The thesis, in brief
The upcoming earnings report could act as a catalyst, with expectations of 15% revenue growth and 8.75% EPS growth.
2 Oct 2025 → 2 Oct 2026
-11.7%
The move
Recent news highlights a 12% gain in the past month, driven by strong adoption of its da Vinci 5 system and expanding international markets.
What to watch
Potential risks include slower U.S. procedure growth and competition from GLP-1 drugs affecting bariatric procedures. Additionally, the stock trades at a premium valuation, which could limit upside if earnings do not meet expectations.
Intuitive Surgical (ISRG) is poised for a potential breakout ahead of its Q3 earnings release on October 20. The company has demonstrated strong fundamentals, including double-digit earnings and revenue growth, and a debt-free balance sheet. Recent news highlights a 12% gain in the past month, driven by strong adoption of its da Vinci 5 system and expanding international markets. The upcoming earnings report could act as a catalyst, with expectations of 15% revenue growth and 8.75% EPS growth.
Potential risks include slower U.S. procedure growth and competition from GLP-1 drugs affecting bariatric procedures. Additionally, the stock trades at a premium valuation, which could limit upside if earnings do not meet expectations.
Unusual participation, not a stampede: the curve peaks between 1.7× and 3×.
Close at the 20-session high. At the breakout door.
Close location over three sessions.
20 sessions vs the market.
Tape observations (not a catalyst). Terms such as RVOL or ATR stay secondary.
Common stocks and ADRs on NYSE and NASDAQ. Price, dollar volume and a complete recent tape. Not OTC, ETFs or warrants.
Every eligible name is scored on the tape. Compression and accumulation on one side; relative volume, closeness to a 20-session high, and strength versus SPY on the other.
Only the shortlist is read for dated news. The AI may keep the quantitative leader, reorder, or refuse the day. A change of #1 needs a stored reason.
One name is published, or NO PICK. Publishing nothing is part of the method.